Click on the title to view the full review or protocol

Log on to The Cochrane Library to read protocols and full reviews. (click here for search tip)

[R] Cochrane review

1. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose  [R]

2. Ayurvedic treatments for diabetes mellitus  [P]
3. Blood pressure targets for hypertension in patients with diabetes mellitus  [P] 
4. Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose  [R]

5. Cinnamon for diabetes mellitus  [P]

6. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia  [R]  [S]
7. HMG CoA reductase inhibitors (statins) for dialysis patients  [R]

8. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2  [R]

9. 'Human' insulin versus animal insulin in people with diabetes mellitus  [R]  [S]
10. Immunotherapy for diabetic amyotrophy  [R]
11. Inhaled insulin in diabetes mellitus  [R]  [s]

12. Insulin and oral agents for managing cystic fibrosis-related diabetes  [R]

13. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings  [R]

14. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus  [R]

15. Metformin for people with impaired glucose tolerance or impaired fasting blood glucose  [P]

16. Mobile phone messaging - a telemedicine for people with diabetes mellitus  [P]

17. Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus  [P]

18. Perioperative glycaemic control for diabetic patients undergoing surgery  [P]

19. Pramlintide for diabetes mellitus  [P]

20. Psychological and pharmacological interventions for depression in patients with diabetes mellitus  [P]

21. Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus  [R]

22. Screening for gestational diabetes mellitus for improving maternal and infant health  [P]

23. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus  [R]  [S]
24. Specialist nurses in diabetes mellitus  [R]  [s]
25. Systems for routine surveillance for people with diabetes mellitus  [R]

26. Theory-based behavioural interventions for prediabetic state and people with diabetes mellitus  [P]

27. Treatment of periodontal disease for glycaemic control in people with diabetes  [R]

Back to Top

1. Continuous glucose monitoring systems for type 1 diabetes mellitus  [P]
2. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus  [P]
3. Intermediate acting versus long acting insulin for type 1 diabetes mellitus  [R]
4. Herbal medicines for type 1 diabetes mellitus  [P]
5. Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents  [R]
6. Physical exercise for type 1 diabetes mellitus  [P]
7. Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus  [R]  [s]

Back to Top

1. Alpha-glucosidase inhibitors for type 2 diabetes mellitus  [R]
2. Chinese herbal medicines for type 2 diabetes mellitus  [R]  [S]
3. Combinations of insulin and oral hypoglycaemic agents for people with type 2 diabetes mellitus on insulin treatment  [P]
4. Computer-assisted versus oral-and-written dietary history taking for diabetes mellitus  [P]
5. Computer-assisted versus oral-and-written family history taking for identifying people with elevated risk of type 2 diabetes mellitus  [P]
6. Continuous glucose monitoring systems for type 2 diabetes mellitus  [P]
7. Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups  [R]
8. Dietary advice for the prevention of type 2 diabetes mellitus in adults  [R]
9. Dietary advice for treatment of type 2 diabetes mellitus in adults  [R]  [S]
10. Different insulin regimens for type 2 diabetes mellitus  [P]
11. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus  [R]
12. Exercise for type 2 diabetes mellitus  [R]
13. Exercise or exercise and diet for preventing type 2 diabetes mellitus  [R]
14. Family based interventions to improve outcomes in patients with type 2 diabetes mellitus  [P]
15. Glucagon-like peptide analogues for type 2 diabetes mellitus  [P]
16. Group based training for self-management strategies in people with type 2 diabetes mellitus  [R]  [S]
17. Individual patient education for people with type 2 diabetes mellitus  [P]
18. Insulin monotherapy versus combinations of insulin with oral antihyperglycaemic agents in patients with type 2 diabetes mellitus  [R]  [S]
19. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus  [R]  [S]
20. Long-acting insulin analogue versus another long-acting insulin analogue for type 2 diabetes mellitus  [P]
21. Long acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus  [R]
22. Long-term non-pharmacological weight loss interventions for type 2 diabetes in adults  [R]
23. Meglitinide analogues for type 2 diabetes mellitus  [R]
24. Metformin for type 2 diabetes mellitus  [R]
25. Momordica charantia for type 2 diabetes mellitus  [R]
26. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus  [R]
27. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus  [R]  [S]
28. Pioglitazone for type 2 diabetes mellitus  [R]
29. Probucol for type 2 diabetes mellitus  [P]
30. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus  [R]  [s]
31. Rosiglitazone for type 2 diabetes mellitus  [R]
32. Screening for type 2 diabetes mellitus  [P]
33. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin  [R]  [S]
34. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus  [P]
35. Whole grain foods for the prevention of type 2 diabetes mellitus  [R]

Back to Top

1. Interventions for latent autoimmune diabetes in adults (LADA)  [R]

Back to Top

Diabetic Coma

Back to Top

Diabetic Ketoacidosis

Back to Top

Obesity in Diabetes

1. Long-term weight loss interventions for type 2 diabetes in adults  [R]
2. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus  [R]

Back to Top

Pregnancy in Diabetes

1. Alternative strategies for diagnosing gestational diabetes mellitus to improve maternal and infant health  [P]
2. Dietary advice in pregnancy for preventing gestational diabetes mellitus  [R]
3. Exercise for diabetic pregnant women  [R]
4. Preconception care for diabetic women to improve maternal and infant health  [P]
5. Screening and subsequent management for gestational diabetes for improving maternal and infant health  [R]
6. Treatments for gestational diabetes  [R]  [s]

Back to Top

1. Different intensities of glycaemic control (tight versus very tight) for pregnant women with pre-existing diabetes  [P]

Back to Top

No reviews currently available for this topic

Back to Top

Diabetes Complications - Angiopathies

1. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus  [R]

Back to Top

1. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema  [R]
2. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy  [P]
3. Herbal medicine for diabetic retinopathy  [P]
4. Intravitreal steroids for macular edema in diabetes [R]
5. Laser photocoagulation for diabetic retinopathy  [P]
6. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy  [P]
7. Pentoxifylline for diabetic retinopathy  [R]
8. Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy [R]

Back to Top

1. Advanced glycation end product (AGE) inhibitors for preventing the progression of diabetic kidney disease  [P]

2. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease  [R]

3. Chinese medicinal herbs for diabetic kidney disease  [P]

4. Education programmes for people with diabetic kidney disease  [P]

5. Pentoxifylline for diabetic kidney disease  [P]

6. Prostaglandin E1 for preventing the progression of diabetic kidney disease  [R]

7. Protein restriction for diabetic renal disease  [R]

8. Sodium ferulate for preventing the progression of diabetic kidney disease  [P]

Back to Top

No reviews currently available for this topic

Back to Top

No reviews currently available for this topic

Back to Top

1. Altered dietary salt intake for preventing and treating diabetic kidney disease  [P]

Back to Top

1. Antihypertensive agents for preventing diabetic kidney disease  [R]
2. Antihypertensive agents for preventing the progression of diabetic kidney disease  [P]

Back to Top

Prevention - Education - Patient education:

1. Complex interventions for preventing diabetic foot ulceration  [R]

2. Patient education for preventing diabetic foot ulceration  [R]  [S]

3. Risk assessment tools for the prevention of pressure ulcers  [R]

Back to Top

Prevention - Pressure redistribution - Orthoses:

1. Pressure relieving interventions for preventing and treating diabetic foot ulcers  [R]

Back to Top

1. Debridement of diabetic foot ulcers  [R]  [S]
2. Electrical stimulation for chronic wounds  [P]
3. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections  [R]
4. Growth factors for treating diabetic foot ulcers  [P]
5. Honey as a topical treatment for wounds  [P]
6. Silver based wound dressings and topical agents for diabetic foot ulcers  [R]  [S]
7. Therapeutic ultrasound for pressure ulcers  [R]
8. Topical agents and dressings for fungating wounds  [R]
9. Topical agents or dressings for pain in venous leg ulcers  [R]

Back to Top

1. Pressure relieving interventions for preventing and treating diabetic foot ulcers  [R]

Back to Top

1. Hyperbaric oxygen for chronic wounds  [R]

Back to Top

Aldose reductase inhibitors for prevention/treatment:

1. Acupuncture for symptomatic treatment of diabetic peripheral neuropathy  [P]
2. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy  [R]
3. Enhanced glycemic control for preventing and treating diabetic neuropathy  [P]

Back to Top

1. Chinese herbal medicine for diabetic peripheral neuropathy  [P]

Back to Top

No reviews currently available for this topic

Back to Top

1. Decompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathy  [R]
2. Duloxetine for treating painful neuropathy or chronic pain  [R]
3. Topiramate for treating painful neuropathy or acute or chronic pain  [P]

Back to Top

1. Efficacy and safety of vardenafil in men with diabetes and erectile dysfunction  [P]
2. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus  [R]